Integra LifeSciences Holdings Corporation $IART Shares Sold by Villanova Investment Management Co LLC

Villanova Investment Management Co LLC trimmed its position in Integra LifeSciences Holdings Corporation (NASDAQ:IART) by 57.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,226 shares of the life sciences company’s stock after selling 24,998 shares during the period. Villanova Investment Management Co LLC’s holdings in Integra LifeSciences were worth $401,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. CWM LLC increased its position in shares of Integra LifeSciences by 413.8% in the 1st quarter. CWM LLC now owns 6,664 shares of the life sciences company’s stock valued at $147,000 after acquiring an additional 5,367 shares during the period. Teacher Retirement System of Texas acquired a new position in shares of Integra LifeSciences in the 1st quarter valued at $223,000. NorthRock Partners LLC acquired a new position in shares of Integra LifeSciences in the 4th quarter valued at $251,000. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Integra LifeSciences in the 1st quarter valued at $251,000. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of Integra LifeSciences in the 1st quarter valued at $277,000. 84.78% of the stock is owned by institutional investors and hedge funds.

Integra LifeSciences Price Performance

Shares of IART opened at $15.39 on Thursday. The business’s 50-day moving average is $13.54 and its two-hundred day moving average is $15.65. The company has a market capitalization of $1.20 billion, a P/E ratio of -2.36, a P/E/G ratio of 0.87 and a beta of 1.20. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.73 and a current ratio of 1.23. Integra LifeSciences Holdings Corporation has a fifty-two week low of $11.06 and a fifty-two week high of $27.13.

Integra LifeSciences (NASDAQ:IART) last announced its quarterly earnings results on Thursday, July 31st. The life sciences company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The company had revenue of $415.61 million for the quarter, compared to the consensus estimate of $395.06 million. Integra LifeSciences had a positive return on equity of 12.15% and a negative net margin of 30.87%.The firm’s revenue for the quarter was down .6% compared to the same quarter last year. During the same period last year, the firm earned $0.63 EPS. Integra LifeSciences has set its FY 2025 guidance at 2.190-2.290 EPS. Q3 2025 guidance at 0.400-0.450 EPS. Research analysts predict that Integra LifeSciences Holdings Corporation will post 2.45 earnings per share for the current year.

About Integra LifeSciences

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.